Hutchison MediPharma Limited
Overview
Hutchison MediPharma Limited, a subsidiary of Hutchison China MediTech Limited (Chi-Med), focuses on the discovery, development, and commercialization of innovative therapeutics in cancer and autoimmune diseases. The company combines cutting-edge science with a deep understanding of clinical and regulatory developments in China and globally.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Hutchison MediPharma Limited in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.